Register Login

ZURA BIO LIMITED (ZURA)

(10% Negative) ZURA BIO LIMITED (ZURA) Announces Delay in identified Development Timeline Due to Geopolitical Situation, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Full text
Register to leave comments
  • News bot March 10, 2026, 10:42 a.m.

    📋 ZURA BIO LIMITED (ZURA) - Clinical Trial Update

    Filing Date: 2026-03-10

    Accepted: 2026-03-10 06:40:47

    Event Type: Clinical Trial Update

    Event Details:

    ZURA BIO LIMITED (ZURA) Announces Clinical Trial Update ZURA BIO LIMITED (ZURA) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: identified
    • Clinical Stage: clinical trial
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Geopolitical Situation, Patient Enrollment, Regulatory Process
    • Collaboration: Zura Bio’s
      • anticipated in 1H 2027
      • anticipated in Q4 2026
      • Targeting interconnected immune pathways in systemic sclerosis 26 BAFF- and IL-17–driven inflammation may contribute to vasculopathy and fibrosis, supporting evaluation of multi-pathway therapeutic strategies in SSc BAFF signaling supports survival of autoreactive B cells Elevated autoantibody production and cytokine networks (including IL-6, IL-17) are observed in SSc Immune-mediated endothelial dysfunction contributes to impaired blood flow Inflammatory cytokines (IL-6, IL-17) thought to promote immune cell infiltration and vascular injury Fibroblast activation contributes to progressive tissue fibrosis Excess extracellular matrix deposition (e.g., collagen) is characteristic of SSc INFLAMMATION VASCULOPATHY FIBROTIC REMODELING Sources: Allanore, Y. et al. (2015

    🔬 Clinical Development Pipeline (ZURA BIO LIMITED):

    Product Type Development Stage Therapeutic Area Source
    WZTL-002 CAR T-cells BIOLOGICAL Phase PHASE2 Large B-cell Lymphoma ClinicalTrials.gov
    Cyclophosphamide DRUG Phase PHASE2 Large B-cell Lymphoma ClinicalTrials.gov
    Fludarabine DRUG Phase PHASE2 Large B-cell Lymphoma ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: ZURA BIO LIMITED
    • Ticker Symbol: ZURA

Search

News categories